What the Study Found (In Plain English)
Published in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2026), this randomized controlled trial evaluating 197 human participants investigated: This report sought to employ multi-modal integration of pre-treatment brain (electroencephalogram, resting-state functional magnetic resonance imaging) and blood (immune and metabolic) biomarkers to facilitate causal inference-based treatment selection by virtue of establishing predictability of remission to multi-stage antidepressant treatment. Key clinical takeaway: While the accuracy of observed outcomes across treatment arms was 82%, the accuracies of predicted...
Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers
Primary Endpoint & Quantitative Summary (Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026-02-15; N = 197; Rigor 88/100): While the accuracy of observed outcomes across treatment arms was 82%, the accuracies of predicted counterfactual (unobserved) outcomes warrant future prospective studies.
Study Limitations & Caveats Before You Act
Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.